We use cookies to ensure that our site works correctly and provides you with the best experience. If you continue using our site without changing your browser settings, we'll assume that you agree to our use of cookies. Find out more about the cookies we use and how to manage them by reading our cookies policy. Hide

Meet the committee

Chair's message

In 2015, Tiffany Wood (Formulation Forum Secretary) proposed the formation of a ‘forum’ within SCI to meet the growing needs and opportunities in the area of formulation. Now, with endorsement from several technical interest groups and hard work from many people along the way the SCI Formulation Forum (FF) is up and running.

With many scientific and industry centres, groups and organisations already present in the ‘formulation community’ it is important that the Formulation Forum contributes to this community in a way that supports the existing groups and brings something new. Within SCI there is clearly an opportunity where common formulation related topics can be addressed at a broader level above the more focused technical interest groups.

Importantly, SCI is a place where academia and business meet and it is this interface where formulation related science not only resides but thrives, and by combining both academic and industrial knowledge and expertise, formulation innovation and creativity can reach levels and achieve goals that cannot be realised individually by academia and industry alone. The science underpinning formulation design and performance covers such a broad area but it fundamentally involves all sciences that can help in understanding, designing, creating, testing, analysing, processing and manufacturing of formulations. Today we are in a ‘golden age’ of formulation innovation since the gap between academic understanding of complex multicomponent systems such as formulations and the real-world complexity of formulations has shrunk to the point where it is no longer a barrier to successful academic-industry collaboration creating exciting new opportunities.

It is at this dynamic academic-industry interface where the Formulation Forum aims to function, it should act as a catalyst for research and innovation for formulation related science, knowledge and expertise. It is a place where:

  • all formulators can openly discuss their needs in a receptive, non-competitive environment with academia and other experts; thus providing a fertile environment for the development of new opportunities and solutions.
  • for academia to openly discuss research and ideas with business to enable future research to be inspired by real-world challenges and opportunities.
  • for other experts working in the formulation business (e.g. patent attorneys, open innovation champions, entrepreneurs and marketers) to liaise with scientists across sectors and help improve the innovation process.

The last point is especially important since an effective formulation also creates important intellectual property opportunities and must connect with market and business needs and opportunities. In this regard a clear understanding of the performance and function requirements which a formulation must perform in the market is a key requirement to any design process alongside a good understanding of the formulation composition-performance relationship.

For the benefit of researchers new to the area of formulation design please note that for the purposes of this forum, formulation related science covers all aspects involved in combining different components in order to form an effective product, e.g. recipes, creation and stabilisation of nano- and micro-particles, physical structures, (bio)interfaces, processes, stability, (bio)delivery, efficacy and consumer perception to name but a few.

If you are interested to learn more about the formulation world and the dynamic academic-industry interface and want to contribute to the Formulation Forum please contact us at membership@soci.org.

Thank you.
Malcolm Faers
Formulation Forum Chair

Committee biographies and photographs

Malcolm Faers

Malcolm Faers, Bayer AG
Malcolm studied colloid science at Imperial College and is a Formulation Scientist with 30 years industrial formulation experience in coatings and crop protection. Areas of interest include the stability of colloidal suspensions, ageing of particle networks, rheology and enhancement of biodelivery of actives through formulation design. He has previously served on the SCI/RSC Colloids Group committee, co-organised several scientific conferences and is a Bayer Science Fellow.

Tiffany Wood

Tiffany Wood, University of Edinburgh
Tiffany runs the Edinburgh Complex Fluids Partnership (ECFP) which offers collaborative research and consultancy to industry, particularly in the area of formulation science. ECFP is embedded within the Soft Matter Physics group (with around 40 researchers) covering experimental colloid science, rheology, characterisation, interface technology, protein behaviour, computer modelling of soft matter systems and the physics of microorganisms such as bacteria.
Additionally, Tiffany holds a Royal Society Industry Fellow and has an SCI funded PhD studentship to examine colloid behaviour in liquid crystalline media.

Jim Bullock

Jim Bullock, iFormulate
Jim is a co-founder and director of iFormulate Ltd. Previously Jim was CEO of Intelligent Formulation Ltd which promoted formulation technology in the UK. After a D.Phil from Oxford, Jim led R&D projects in imaging at Ilford Ltd and activities on crystal engineering and dye formulation and chemistry at ICI/Zeneca. At BASF, in UK and Germany, Jim headed formulation development for colours and held marketing, strategy, R&D and regulatory affairs functions for BASF’s global biocides business. Jim was also a board director of Agion Technologies, USA.

Communications Officer:
Jade Owen

Jade Owen, Intertek Melbourn, Cambridgeshire
Jade successfully runs her own LinkedIn community for ICP-OES and ICP-MS analyses which now has over 7000 members. From this she has contributed to the social media strategy for SCI’s Agrisciences committee and she plans to do the same with the Formulation Forum.
Jade works as a method development and validation scientist at Intertek Melbourn. The company works on a wide variety of pharmaceutical products and specialises in inhalation medicines and has a formulation laboratory.

Committee Members:
Richard Greenwood

Richard Greenwood, University of Birmingham
• EngD Programme Manager at the Centre for Formulation Engineering, School of Chemical Engineering, University of Birmingham since 2001
• Member of SCI’s Colloid and Surface Chemistry Committee

Andrew Howe

Andrew Howe, Adquot Ltd
• Science-based formulation expertise from major multinational, through university to SME
• Designing material compositions (polymer, surfactant, colloid) to achieve optimal properties in product and process
• Industry experience:
     • 20 years at Kodak (photographic, inkjet materials)
     • 5 years at Schlumberger (drilling fluids, enhanced oil recovery)
     • Visiting researcher at Cambridge University (since 2009, giving lectures on
       rheology of suspensions and on surfactants)
     • Recently started employment at Aqdot, an SME spun out from Cambridge
       University, that uses host-guest complexation for purposes of
       encapsulation and release of materials

Craig Duckham

Craig Duckham, CD R&D Consulting
After 9 years working in microencapsulation contract development and technology transfer Craig formed his own consultancy services company in 2012. CD R&D Consultancy Services operates across multiple sectors and provides long and short term technical support and know-how to both mature and developing businesses.
Craig has a background in plant and crop sciences and analytical chemistry and has worked on projects including the controlled release of food flavours and crop protection active ingredients.
Craig is a Fellow of the Institute of Food Science and Technology (IFST) and a Member of the Royal Society of Biology with a PhD in Plant Physiology from The University of Nottingham. He is also Chair of SCI’s Food Committee.

Neil Campbell

Neil Campbell, Sagentia Ltd
Neil has over 20 years of experience in the development of formulation and process science products across a wide variety of industries including Pharmaceutical, Catalysis, Personal Care & Beauty, Pest Control, Home Care & Hygiene, Surfactants, Polymers, Electronics Materials, Inks and Dyes and Food & Beverage
He has designed and helped to build a number of multimillion pound advanced R&D centres including the Centre of Materials Discovery in Liverpool. He has also developed and implemented a number of techniques and pieces of equipment with major suppliers for high throughput research in the area of formulation and process development from laboratory to scale up to reduce product time to market.
Currently Global VP for FMCG / CPG Business Development at Sagentia Ltd in Cambridge, Neil also helps CPG companies around the world with their corporate R&D strategy and innovating with and around their formulation products in areas such as,
• R&D Enabling Equipment and Consumer Insights Tools
• Devices and Systems to empower the formulation
• Process Improvement and innovation
• Brand Activation and consumer sensorial engagement technologies

Carl Formstone

Carl Formstone, Syngenta
Carl's background is as a chemistry graduate. Working as a Formulation Chemist in the UK near Bracknell and currently leading a colloid science team at the Jealott’s Hill Research Station for Syngenta. He has had 25 years of experience in the crop protection industry across a range of diverse projects and his main focus has been herbicidal agents at different stages of development from discovery to scale-up and manufacture.

Robin Harrison

Robin Harrison, Synthomer
Robin is the Global Innovation Director at Synthomer with overall responsibility for group R&D strategy and product & polymer technology development activities at the company’s research centres in Europe, Asia and the USA. He has close to 20 years experience of polymer chemistry with a focus on application areas such as coatings, adhesives, textiles and paper where formulation technology is central to developing industrially relevant systems. Robin obtained his PhD from the University of Sussex in Organic & Polymer Chemistry and carried out postdoctoral research at the University of Colorado and The IRC in Polymer Science & Technology in Durham. He has extensive international experience and has spent over 10 years living in the USA and The Netherlands.

James Humphrey

James Humphrey, Croda
James obtained an MChem at the University of Hull in 2007 and started work at Croda (Snaith, East Yorkshire, UK) in the same year. James’ work at Croda has focused on formulating with Croda’s current range of surfactants, oils and other speciality chemicals used in formulated products from paints to pharmaceuticals to engine lubricants. James leads the new surfactant and formulation development teams for Personal Care, focusing on formulation science to develop new green and sustainable surfactants. More recently James has switched focus to the understanding and development of excipients for the pharmaceutical sector, with particular interest on the role of the excipient type and quality on the stability and delivery of drugs in injectable, topical and oral dosage forms. James has an overarching interest in understanding the intricacies of formulation from what seem like such “simple” blends of material on paper.

Neil Simpson

Neil Simpson, OMG Borchers GmbH
Neil joined OMG Borchers as R&D Manager in 2014 and is now responsible for managing teams and coordinating collaborations globally for the development of additives for the CASE markets. Prior to joining OMG, he was part of the team that launched a company called Hydra Polymers from Unilever; working in a venture capital environment as Head of Technical Development, developing and leading collaborative projects for a variety of markets including inks, coatings, water treatment and oilfield. His technical background is in synthetic polymer chemistry, where his research interests in catalytic transformations, controlled polymer architecture and dendritic structures were applied to areas such as resin development, conducting polymers, hydrogels and ‘green’ polymerization. A particular achievement was to be a pioneer in creating semi-crystalline thiol-ene networks, made possible by utilizing enzymatic catalysis. He has a PhD from Stratchlyde University and won the North West SCI (graduate) Award in 2002.

Paul Bartlett

Paul Bartlett, University of Bristol
• Wide experience of soft matter science with particular interests in colloids, polymers, and surfactants.
• Expertise in the development and application of quantitative techniques (such as laser trapping, confocal microscopy, rheology, and scattering methods) to problems in soft matter science, Goal is to understand how the structure and dynamics at a mesoscopic scale dictate the bulk physical properties of soft materials.
• Collaborated with a wide range of industrial partners (Bayer, GSK, Merck, Syngenta, and Unilever) and worked at ICI for a few years.

Jason Tierney

Jason Tierney, Discovery from Charles River Laboratories
Jason has almost 20 years’ experience as a Medicinal Chemist in Drug Discovery with multiple patents and publications. He is currently a Principal Scientist and Project Leader in Medicinal Chemistry at Discovery from Charles River. Charles River acquired Argenta and BioFocus in May 2014 enabling it to develop a full service, early-stage contract research organization (CRO), with integrated in vitro and in vivo capabilities from target discovery through to preclinical development. Jason started at BioFocus in early 2009. Previously, Jason was a Team Leader in Medicinal Chemistry at GSK from 2002 and prior to that at Organon Research from 1997 as a Senior Chemist. He was a postdoctoral researcher at the Universite Pierre at Marie Curie, Paris in the lab of Prof Alex Alexakis between 1995 and 1997. Jason obtained his PhD in Organic Chemistry at Imperial College, London in 1995 under Prof Donald Craig following his graduation in 1992.

Jason is also a member of the SCI Fine Chemicals Group and has an interest in the impact of formulation on drug delivery. He also Chair of the UK Automated Synthesis Forum (UKASF).

Colin Bain

Colin Bain, Durham University
Colin Bain completed a BA in Natural Sciences in Cambridge, England, and a PhD in Physical Chemistry at Harvard University under the supervision of Prof George Whitesides. He returned to the UK as a Royal Society Research Fellow in Cambridge before moving to Oxford as University Lecturer and Fellow of Magdalen College in 1991. He has been a Professor of Chemistry at Durham University since 2005. From 2008–12 he was the Director (Science) at the Institute of Advanced Study. Since 2015 he has been Dean for Research at Durham University.

His research lies at the intersection of physical chemistry with physics, engineering and biology. While broadly in the field of ‘wet surface chemistry’, his interests range from the break-up of jets to drying of droplets on surfaces, from phase transitions to adsorption kinetics, from tertiary oil recovery to model cell membranes. Much of his work is collaborative within Durham (Physics, Chemistry & Engineering), the UK (Oxford, Cambridge, Bristol, Imperial, Sheffield, Leeds) and around the world (USA, India, Japan). He collaborates widely with industry in the UK, Europe and Japan.

His research has been recognised by both natio nal and international awards, including the Corday-Morgan Medal (2000), Tilden Prize (2008), Thomas Graham Lecturer (2011), Craig Lecturer (ANU, 2008), McBain Lecturer (National Chemical Laboratory, Pune, India, 2005), Lectureship Award of the Japanese Chemical Society (2005) and Fellow of the Society of Applied Spectroscopy (2014). He served for 12 years on the Editorial Advisory Board of Langmuir and was a founding editor Soft Matter. He has published over 160 papers with >12,000 external citations and an h-index of 42.

Share this article